Search Results - "Foss, Joseph"

Refine Results
  1. 1

    An overview of the cannabinoid type 2 receptor system and its therapeutic potential by Bie, Bihua, Wu, Jiang, Foss, Joseph F, Naguib, Mohamed

    Published in Current opinion in anaesthesiology (01-08-2018)
    “…This narrative review summarizes recent insights into the role of the cannabinoid type 2 (CB2) receptor as potential therapeutic target in neuropathic pain and…”
    Get full text
    Journal Article
  2. 2

    Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer’s Rodent Models by Bie, Bihua, Wu, Jiang, Foss, Joseph F., Naguib, Mohamed

    Published in Molecular neurobiology (01-08-2019)
    “…Microglia and complements appear to be involved in the synaptic and cognitive deficits in Alzheimer’s disease (AD), though the mechanisms remain elusive. In…”
    Get full text
    Journal Article
  3. 3

    Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease by Wu, Jiang, Hocevar, Mark, Foss, Joseph F., Bie, Bihua, Naguib, Mohamed

    Published in European journal of pharmacology (15-09-2017)
    “…Alzheimer's disease (AD) is a neurodegenerative disorder characterized by neuroinflammation, extensive deposits of amyloid-β aggregates, and loss of memory and…”
    Get full text
    Journal Article
  4. 4

    Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses by Wu, Jiang, Bie, Bihua, Foss, Joseph F., Naguib, Mohamed

    Published in Molecular neurobiology (01-05-2020)
    “…The complement C1q plays a critical role in microglial phagocytosis of glutamatergic synapses and in the pathogenesis of neuroinflammation in Alzheimer’s…”
    Get full text
    Journal Article
  5. 5

    Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses by Bie, Bihua, Wu, Jiang, Foss, Joseph F., Naguib, Mohamed

    Published in Hippocampus (01-08-2018)
    “…Silent glutamatergic synapses lacking functional AMPA (α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazoleproprionate) receptors exist in several brain regions including…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability by Viscusi, Eugene R., Gan, Tong J., Leslie, John B., Foss, Joseph F., Talon, Mark D., Du, Wei, Owens, Gay

    Published in Anesthesia and analgesia (01-06-2009)
    “…Postoperative ileus (POI), a transient cessation of coordinated bowel function after surgery, is an important health care problem. The etiology of POI is…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A Review of the Potential Role of Methylnaltrexone in Opioid Bowel Dysfunction by Foss, Joseph F

    Published in The American journal of surgery (01-11-2001)
    “…Opioids are widely used analgesics in patients with advanced cancer. However, their effectiveness for pain relief is often limited by the most frequently…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial by Yuan, Chun-Su, Wei, Gang, Foss, Joseph F, O'Connor, Michael, Karrison, Theodore, Osinski, Joachim

    “…Methylnaltrexone, the first peripheral opioid receptor antagonist, has the potential to prevent or reverse opioid-induced peripherally mediated side effects…”
    Get more information
    Journal Article
  13. 13

    Comparing methods of clinical measurement : Reporting standards for Bland and Altman analysis by MANTHA, S, ROIZEN, M. F, FLEISHER, L. A, THISTED, R, FOSS, J

    Published in Anesthesia and analgesia (01-03-2000)
    “…In this era of medical technology assessment and evidence-based medicine, evaluating new methods to measure physiologic variables is facilitated by…”
    Get full text
    Journal Article
  14. 14

    Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use: A Randomized Controlled Trial by Yuan, Chun-Su, Foss, Joseph F, O'Connor, Michael, Osinski, Joachim, Karrison, Theodore, Moss, Jonathan, Roizen, Michael F

    “…CONTEXT Constipation is the most common chronic adverse effect of opioid pain medications in patients who require long-term opioid administration, such as…”
    Get full text
    Journal Article
  15. 15

    Are Peripheral Opioid Antagonists the Solution to Opioid Side Effects? by Bates, John J., Foss, Joseph F., Murphy, Damian B.

    Published in Anesthesia and analgesia (01-01-2004)
    “…Opioid medication is the mainstay of therapy for severe acute and chronic pain. Unfortunately, the side effects of these medications can affect patient comfort…”
    Get full text
    Journal Article
  16. 16

    Use of the CTrach Laryngeal Mask Airway in adult patients: a retrospective review of 126 cases by Maurtua, Marco A., MD, Fernando, Michael, MD, Finnegan, Patrick S., NREMT-B, Mehta, Behram, MS4, Wu, Jiang, MD, Foss, Joseph, MD, Perilla, Mauricio, MD, Zura, Andrew, MD, Doyle, D. John, MD, PhD

    Published in Journal of clinical anesthesia (01-08-2012)
    “…Abstract Study Objective To evaluate the effectiveness of the CTrach Laryngeal Mask Airway (LMA) when used electively. Design Retrospective analysis. Setting…”
    Get full text
    Journal Article
  17. 17

    Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use by Yuan, Chun-Su, Foss, Joseph F., Williams, Wade A., Moss, Jonathan

    Published in Drug development research (01-09-2009)
    “…Opioid medications are used extensively as potent analgesics for treating moderate to severe pain. Although opioids offer reliable pain relief, their use is…”
    Get full text
    Journal Article
  18. 18

    A phase I single ascending dose safety study of NTRX‐07 in normal volunteers by Foss, Joseph, Naguib, Mohamed, Giordano, Tony

    Published in Alzheimer's & dementia (01-12-2020)
    “…Background NTRX‐07 is a selective cannabinoid receptor type 2 (CB2) agonist that has been shown in animal models to be effective for the treatment of…”
    Get full text
    Journal Article
  19. 19

    A phase I single ascending dose safety study of NTRX‐07 in normal volunteers: Human/Human trials: Inflammation by Foss, Joseph, Naguib, Mohamed, Giordano, Tony

    Published in Alzheimer's & dementia (01-12-2020)
    “…Abstract Background NTRX‐07 is a selective cannabinoid receptor type 2 (CB 2 ) agonist that has been shown in animal models to be effective for the treatment…”
    Get full text
    Journal Article
  20. 20

    Effects of Low-Dose Morphine on Gastric Emptying in Healthy Volunteers by Yuan, Chun-Su, Foss, Joseph F., O'Connor, Michael, Roizen, Michael F., Moss, Jonathan

    Published in Journal of clinical pharmacology (01-11-1998)
    “…Appropriate preoperative pain therapy for patients undergoing surgery may be withheld due to the fear that opioids will inhibit gastric emptying and increase…”
    Get full text
    Journal Article